OXIGENE, INC.

Company

Oncotelic Therapeutics, Inc.

Filed

November 10, 2009

Period of Report

September 30, 2009

Accession Number

0000950123-09-060729

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →